Mumbai, June 10 -- Hemant Surgical Industries has completed the strategic acquisition of a majority stake (66.66%) in Lifesenz Cancer Research Labs (Lifesenz), a company focused on precision oncology and personalized cancer treatment solutions for an amount of Rs. 19.98 crore, making Lifesenz a subsidiary of the Company with effect from 01 June 2026.

Published by HT Digital Content Services with permission from Capital Market....